MRNA Jun 2024 170.000 call
| Previous close | 0.2000 |
| Open | 0.1200 |
| Bid | 0.0600 |
| Ask | 0.2000 |
| Strike | 170.00 |
| Expiry date | 2024-06-21 |
| Day's range | 0.1200 - 0.2000 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.36k |
- Yahoo Finance Video
Moderna: FDA postpones RSV vaccine approval
Moderna (MRNA) has announced a setback in the anticipated approval of its RSV vaccine. The biopharmaceutical company says that the US Food and Drug Administration (FDA) has postponed the decision to approve the vaccine until the end of May due to administrative constraints. Yahoo Finance's health reporter Anjalee Khemlani breaks down the details. For more expert insight and the latest market action, click here to watch this full episode of Catalysts. This post was written by Angel Smith
Investor's Business DailyModerna Seesaws After The FDA Throws A Curveball On Its Second Product
Moderna stock seesawed Friday after the Food and Drug Administration delayed an approval decision on its RSV vaccine until the end of the month.
Barrons.comFDA Delays Decision on Moderna RSV Shot by 3 Weeks
The agency was originally scheduled to announce its call on Sunday. The company said it hadn’t flagged any issues with the drug’s safety, efficacy, or quality.
